Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 5, 1999, Pages 705-708

  Cotarelo, Manuel ^a   Catalán, Pilar ^a   Sánchez Carrillo, Carlos ^a   Menasalvas, Ana ^a   Cercenado, Emilia ^a   Tenorio, Antonio ^b   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FOSCARNET;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CYTOPATHOGENIC EFFECT; DRUG RESISTANCE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; NONHUMAN; VERO CELL;

ACYCLOVIR; ANTIVIRAL AGENTS; FOSCARNET; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MICROBIAL SENSITIVITY TESTS; PLAQUE ASSAY; SENSITIVITY AND SPECIFICITY;

EID: 0032714540     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.5.705     Document Type: Article

References (9)

1. Arvin, A. M. & Prober, C. G. (1995). Herpes simplex viruses. In Manual of Clinical Microbiology, 6th edn, (Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds), pp. 876-83. American Society for Microbiology, Washington, DC.
2. Hirsch, M. S. (1995). Herpes simplex virus. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 4th edn, (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 1336-45. Churchill Livingstone, New York.
3. Chatis, P. A. & Crumpacker, C. S. (1992). Resistance of herpesviruses to antiviral drugs. Antimicrobial Agents and Chemotherapy 36, 1589-95.
4. Englund, J. A., Zimmerman, M. E., Swierosz, E. M., Goodman, J. L., Scholl, D. R. & Balfour, H. H. (1990). Herpes simplex virus resistant to acyclovir: a study in a tertiary care center. Annals of Internal Medicine 112, 416-22.
5. Erlich, K. S., Mills, J., Chatis, P., Mertz, G. J., Busch, D. F., Follansbee, S. E. et al. (1989). Acyclovir resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. New England Journal of Medicine 320, 293-6.
6. Field, A. K. & Biron, K. K. (1994). 'The end of innocence' revisited: resistance of herpesviruses to antiviral drugs. Clinical Microbiology Reviews 7, 1-13.
7. Safrin, S., Elbeik, T., Phan, L., Robinson, D., Rush, J., Elbaggari, A. et al. (1994). Correlation between response to acyclovir and foscarnet therapy and in-vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrobial Agents and Chemotherapy 38, 1246-50.
8. Sweirkosz, E. M. & Biron, K. K. (1994). Antiviral susceptibility testing. In Clinical Microbiology Procedures Handbook, Supplement 1, (Isenberg, H. D., Ed.), pp. 8.26.1-21. American Society for Microbiology, Washington, DC.
9. Sweirkosz, E. M. & Biron, K. K. (1995). Antiviral agents and susceptibility testing. In Manual of Clinical Microbiology, 6th edn, (Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds), pp. 1415-23. American Society for Microbiology, Washington, DC.